Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces robust neutralizing salivary IgA
Miri Stolovich-Rain(Hebrew University of Jerusalem), Alexander Rouvinski(Atkins (United States)), Dana G. Wolf(Hadassah Medical Center), Jacob Strahilevitz(Hebrew University of Jerusalem), Salim Sirhan(Hebrew University of Jerusalem), Hila Elinav(Hebrew University of Jerusalem), Esther Oiknine‐Djian(Hebrew University of Jerusalem), Einav Cohen‐Kfir(Hebrew University of Jerusalem), Dan Padawer(Hebrew University of Jerusalem), Orly Zelig, Kathakali Das(Hebrew University of Jerusalem), Maya Elgrably‐Weiss(Hebrew University of Jerusalem), Yair E. Gatt(Hebrew University of Jerusalem), Ritesh Ranjan Pal(Hebrew University of Jerusalem), Bing Zhou(Southern University of Science and Technology), Michal Bejerano Sagie(Hebrew University of Jerusalem), Yakov Socol(Hebrew University of Jerusalem), Maria Billan(Hebrew University of Jerusalem), Leah Baraz(Hebrew University of Jerusalem), Ahuva Friedman(Hebrew University of Jerusalem), Peretz Golding(Hebrew University of Jerusalem), Saveliy Kirillov(L. N. Gumilyov Eurasian National University), Miriam Ravins(Hebrew University of Jerusalem), Sujata Kumari(Hebrew University of Jerusalem), Reuven Wiener(Hebrew University of Jerusalem)
Cited by 1
Related Papers
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
|Nature Medicine|2005|1k
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
|Clinical Microbiology Reviews|2009|930
Host Immune System Gene Targeting by a Viral miRNA
|Science|2007|642
<i>qnr</i> Prevalence in Ceftazidime-Resistant <i>Enterobacteriaceae</i> Isolates from the United States
|Antimicrobial Agents and Chemotherapy|2006|576